3 edition of Handbook of ocular drug therapy and ocular side effects of systemic drugs found in the catalog.
Published
1991
by Little, Brown in Boston
.
Written in English
Edition Notes
Includes bibliographical references and indexes.
| Statement | Deborah Pavan-Langston and Edmund C. Dunkel. |
| Contributions | Dunkel, Edmund C. |
| Classifications | |
|---|---|
| LC Classifications | RE994 .L35 1991 |
| The Physical Object | |
| Pagination | xi, 464 p. ; |
| Number of Pages | 464 |
| ID Numbers | |
| Open Library | OL1892317M |
| ISBN 10 | 0316695459 |
| LC Control Number | 90061769 |
Ideal for ophthalmologists, optometrists and busy clinicians, Drug-Induced Ocular Side Effects provides the clinically relevant information you need to diagnose and manage chemical and drug-related ocular problems. An easily accessible format, meticulous revisions and comprehensive coverage of all drugs' generic and trade names, primary uses, ocular and systemic side effects, and clinical Pages: adverse ocular side effects secondary to these antineoplastic agents.5 Ocular toxicity induced by cancer chemotherapy includes a broad spectrum of Review Ocular toxicity of systemic anticancer chemotherapy Afekhide Ernest OMOTI, Caroline Edijana OMOTI.
Ideal for ophthalmologists, optometrists and busy clinicians, Drug-Induced Ocular Side Effects provides the clinically relevant information you need to diagnose and manage chemical and drug-related ocular easily accessible format, meticulous revisions and comprehensive coverage of all drugs’ generic and trade names, primary uses, ocular and systemic side effects, and clinical. It is also recognized that other systemic agents and nutraceuticals may impact on the ocular system creating side effects. The clinician should always be cognizant of that possibility when evaluating new patient symptoms. Drug interactions may also contribute to ocular side effects and the pharmacist should be consulted regarding that potential.
The use of mucoadhesive polymers in tear substitutes, ocular drug delivery systems, stem cell therapy, pharmacogenomics and antiangiogenic ocular chemotherapy are also explored. The book also provides insights from drugs of herbal origin, and a historical perspective on drugs for ocular use. Potential Ocular Side Effects of Select Systemic Drugs Pacific University College of Optometry Brandon Reed BS & Len V Hua PhD OD Indications: This retinoid (a form of vitamin A) is used to treat psoriasis, cystic acne, and various other skin conditions. Ocular Side Effects: Optic neuritis, dry eye, decreased night vision, and transitory myopia.
Jesus, God and man.
Two structural types of motor nerve terminals at body-wall muscles of larval Sarcophaga bullata.
30 Years Sleep Apnea Syndrome (Respiration)
Rochesters Poems on several occasions.
Bengt Peter Andersson & Johanna Jönsdotter
Mr. Benton, from the Select Committee to which was referred the proposition to inquire into the expediency of reducing the patronage of the executive government of the United States, made the following report ... [etc.]
Rome for you
Consumption trends and patterns for vegetables
Financial accounting
Ferocious Common Sense
dresses of the mistresses of the White House as shown in the United States National Museum
King James The Sixth Golfing Club
Scientific facilities and information services of the Republic of Viet-Nam
Handbook of ocular drug therapy and ocular side effects of systemic drugs. Boston: Little, Brown, © (OCoLC) Material Type: Internet resource: Document Type: Book, Internet Resource: All Authors / Contributors: Deborah P Langston; Edmund C Dunkel.
Ideal for ophthalmologists, optometrists and busy clinicians, Drug-Induced Ocular Side Effects provides the clinically relevant information you need to diagnose and manage chemical and drug-related ocular problems. An easily accessible format, meticulous revisions and comprehensive coverage of all drugs’ generic and trade names, primary uses, ocular and systemic side effects, and clinical /5(2).
Ocular side effects of systemic drugs 1. OCULAR SIDE EFFECTS OF SYSTEMIC DRUGS PRESENTER- ANJU NAGAR DATE: 2. Introduction • After a drug molecule enters the systemic circulation, it can reach ocular tissues through uveal or retinal circulations.
Systemic Drugs with Ocular Side Effects Elderly patients are often taking medications for osteoporosis, erectile dysfunction and prostate conditions that are known to have ocular side effects. When patients present with ocular conditions that have no apparent cause, it is important to consider whether the condition could be caused by a systemic.
Systemic characterization of ocular drugs mirrors that of systemic drugs, including administration routes (e.g., oral and IV) and evaluation parameters. The decision to evaluate one or two species (one rodent and one non-rodent) depends on multiple factors []: 1.
New medical entities (two species), 2. Known toxicity profiles (one species), 3. Handbook of Drug Therapy and Ocular Side Effects of Systemic Drugs.
Boston: Little, Brown Co, ; reactions to allopurinol range from mild to moderate. Approximately three percent of patients on allopurinol therapy may develop skin eruptions (exfoliative dermatitis), fever, hepatomegaly, leukopenia, gastrointestinal distress, rash Cited by: 5.
Viagra (Levitra and Cialis) are _____ inhibitors that are prescribed for ED. PDE6 found in the retina can be affected by these drugs. What is the main type of ocular side effect.
Increased light sensitivity can also occur (those taking mg of Viagra have a 50% change of ocular side effects while those taking 50mg have a 5% chance). The drug potentially has systemic and ocular side effects. Here, we present ocular side effects in a PCOS patient and emphasize the need to pay attention to visual complaints during treatment.
Ocular Pharmacology Introduction of drugs used in Eyes Gyanendra Lamichhane, MD LEI, Bhairahawa Slideshare uses cookies to improve functionality and performance, and to provide you with relevant advertising. T1 - Ocular adverse effects associated with systemic medications. T2 - Recognition and management.
AU - Santaella, Ricardo M. AU - Fraunfelder, Frederick W. PY - /1/ Y1 - /1/ N2 - This article reviews several retrospective case series and reported adverse events regarding common ocular adverse effects related to systemic by: The underlying principle of the Registry is to generate early signals of adverse ocular reactions.
The data is available to clinicians and researchers and is published in both peer review journals and every years in a book titled Drug-Induced Ocular Side Effects. The 8th edition of Drug-Induced Ocular Side Effects will be available June Written by the founder of The National Registry of Drug-Induced Side Effects, this resource provides clinically relevant information on adverse drug reactions based on authoritative data supplied by the Federal Drug Administration and the World Health Organization.
It includes generic and trade drug names, and covers the primary use, ocular and systemic side effects, and clinical significance. Welcome to the Clinical Guide to Ophthalmic Drugs—the 20th An- Notably, is projected to bring us a newer glaucoma drug and a new drug to help treat dry eye disease.
In addition to sharing with you informa- DRUGS A woman experiencing a severe ocular allergic reaction. Searches focused on: (1) Ocular side/adverse effects of ophthalmic drugs; (2) Ocular side/adverse effects of systemic drugs; (3) Systemic side/adverse effects of ophthalmic drugs.
PubMed was used to perform searches. Limits included: species, human and field tag, abstract/title, dates from 01/01/ to Cited by: 4. Adverse ocular reactions to systemic drug therapy Senior Lecturer Jay Meyer Professor Charles McGhee Department of Ophthalmology Eye Drops: systemic side effects Adverse Drug Events > 2 million hospital visits >deaths Background OTC medicines 40% >60 year olds Prescription medicines Likelihood of side effects depends on:File Size: 3MB.
It is not intended as a comprehensive summary of these well described adverse drug reactions, nor is it intended to cover the complete spectrum of all ocular adverse effects of systemic therapy.
Ocular Toxicity Associated with Systemic Drug Therapy. By Sarah Comments. In this presentation from AAOSarah R. Wellik, MD, discusses the following drugs and their accompanied ocular toxicities: In the future, other systemic medications, including retinoids and systemic anti-hypertensive drugs, might provide new, interesting data.
The book also covers ocular toxicology, focusing on drug interactions, ocular effects of systemic drugs, and life-threatening systemic emergencies.
A logical organization makes it easy to find essential information. Complete coverage of the basic fundamentals of pharmacology such as ocular drug delivery and ocular drug s: 2.
Drugs affecting cornea Systemic drugs and their metabolites reach cornea and lens via the tear film, limbal vasculature and the aqueous humor. Although corneal opacities secondary to drug therapy do not produce much of visual impairment, these opacities may signal more permanent deposit of drugs in the lens and more importantly in the Size: 2MB.
The last section is a review of ocular toxicology, including drug interactions, ocular effects of systemic drugs, and life-threatening systemic emergencies.
Assessment: The authors have succeeded in compiling an excellent ocular pharmacology resource for Price: $. Pavan-Langston D. Handbook of Ocular Drug Therapy and Ocular Side Effects of Systemic Drugs. Boston: Little, Brown, Nussenblatt RB, Palestine AG. Uveitis: Fundamentals and Clinical Practices.
Chicago: Year Book Medical Publishers; Vianna RN, Ozdal PC, Deschenes J, Burnier MN Jr. Combination of azathioprine.1. Author(s): Langston,Deborah P(Deborah Pavan),; Dunkel,Edmund C Title(s): Handbook of ocular drug therapy and ocular side effects of systemic drugs/ Deborah Pavan-Langston and Edmund C.
Dunkel. Edition: 1st ed. Country of Publication: United States Publisher: Boston: Little, Brown, c Description: x, p. This article reviews several retrospective case series and reported adverse events regarding common ocular adverse effects related to systemic therapy.
It is not intended as a comprehensive summary of these well described adverse drug reactions, nor is it intended to cover the complete spectrum of all ocular adverse effects of systemic therapy. Many systemic drugs may Cited by:
